165
Followers
1
Posts
127
KEYMED BIOSCIENCES INC
(HKEX: 2162)
Keymed Biosciences, Inc. is an investment holding company, which engages in the discovery and development of biological therapies in the autoimmune and oncology therapeutic areas. It operates through Hong Kong and China geographical segment. The company was founded on April 23, 2018 and is headquartered in Chengdu, China.
55.800 -
-1.950
(-3.38%)
Range
55.550 - 58.500
(5.31%)
Open
58.500
Previous Close
57.750
Bid Price
55.800
Bid Volume
('000)
0.5
Ask Price
55.850
Ask Volume
('000)
0.5
Volume
('000)
1,023
Value
57,574,788
Remark
-
Delayed prices. Updated at 30 Jan 2026 00:08.
Data powered by
View All Events
165
Loading Chart...
Please login to view stock data and analysis
